U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry RACEMIC
Molecular Formula C17H26ClN3O3.ClH
Molecular Weight 392.321
Optical Activity ( + / - )
Defined Stereocenters 0 / 1
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of BATANOPRIDE HYDROCHLORIDE

SMILES

Cl.CCN(CC)CCNC(=O)C1=C(OC(C)C(C)=O)C=C(N)C(Cl)=C1

InChI

InChIKey=CUTCEGXKJDBAFQ-UHFFFAOYSA-N
InChI=1S/C17H26ClN3O3.ClH/c1-5-21(6-2)8-7-20-17(23)13-9-14(18)15(19)10-16(13)24-12(4)11(3)22;/h9-10,12H,5-8,19H2,1-4H3,(H,20,23);1H

HIDE SMILES / InChI

Molecular Formula ClH
Molecular Weight 36.461
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Molecular Formula C17H26ClN3O3
Molecular Weight 355.86
Charge 0
Count
Stereochemistry RACEMIC
Additional Stereochemistry No
Defined Stereocenters 0 / 1
E/Z Centers 0
Optical Activity ( + / - )

Batanopride, previously known as BMY-25801, a 5-hydroxytryptamine 3 receptor antagonist, was studied against emesis for cancer patients that were treated by chemotherapy procedure. Batanopride had the dose-limiting side effects including hypotension and long QT syndrome that is why any further experiments for its medical application were discontinued.

Approval Year

PubMed

PubMed

TitleDatePubMed
BMY-25801, an antiemetic agent free of D2-dopamine receptor antagonist properties.
1988 Mar
Dose-limiting hypotension with the 5-HT3-antagonist batanopride (BMY-25801).
1991 Feb
A randomized, double-blinded study comparing six doses of batanopride (BMY-25801) with methylprednisolone in patients receiving moderately emetogenic chemotherapy.
1991 Oct

Sample Use Guides

six patient groups each received a single intravenous dose of batanopride ranging from 0.2 to 6.0 mg/kg
Route of Administration: Intravenous
Substance Class Chemical
Created
by admin
on Fri Dec 15 17:34:27 UTC 2023
Edited
by admin
on Fri Dec 15 17:34:27 UTC 2023
Record UNII
00L331RFEC
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
BATANOPRIDE HYDROCHLORIDE
MART.   USAN   WHO-DD  
USAN  
Official Name English
BMY-25801-01
Code English
BENZAMIDE, 4-AMINO-5-CHLORO-N-(2-(DIETHYLAMINO)ETHYL)-2-(1-METHYL-2-OXOPROPOXY)-, MONOHYDROCHLORIDE
Common Name English
Batanopride hydrochloride [WHO-DD]
Common Name English
BATANOPRIDE HYDROCHLORIDE [USAN]
Common Name English
BATANOPRIDE HCL
Common Name English
BATANOPRIDE HYDROCHLORIDE, (±)-
Common Name English
4-AMINO-2-(BUTAN-2-ON-3-YL)OXY-5-CHLORO-N-(2-(DIETHYLAMINO)ETHYL)BENZAMIDE HYDROCHLORIDE
Common Name English
(±)-BATANOPRIDE HYDROCHLORIDE
Common Name English
BATANOPRIDE HYDROCHLORIDE [MART.]
Common Name English
Classification Tree Code System Code
NCI_THESAURUS C66885
Created by admin on Fri Dec 15 17:34:28 UTC 2023 , Edited by admin on Fri Dec 15 17:34:28 UTC 2023
Code System Code Type Description
CAS
102670-59-7
Created by admin on Fri Dec 15 17:34:28 UTC 2023 , Edited by admin on Fri Dec 15 17:34:28 UTC 2023
PRIMARY
PUBCHEM
59691
Created by admin on Fri Dec 15 17:34:28 UTC 2023 , Edited by admin on Fri Dec 15 17:34:28 UTC 2023
PRIMARY
NCI_THESAURUS
C72717
Created by admin on Fri Dec 15 17:34:28 UTC 2023 , Edited by admin on Fri Dec 15 17:34:28 UTC 2023
PRIMARY
FDA UNII
00L331RFEC
Created by admin on Fri Dec 15 17:34:28 UTC 2023 , Edited by admin on Fri Dec 15 17:34:28 UTC 2023
PRIMARY
MESH
C060190
Created by admin on Fri Dec 15 17:34:28 UTC 2023 , Edited by admin on Fri Dec 15 17:34:28 UTC 2023
PRIMARY
USAN
AA-77
Created by admin on Fri Dec 15 17:34:28 UTC 2023 , Edited by admin on Fri Dec 15 17:34:28 UTC 2023
PRIMARY
EPA CompTox
DTXSID30907977
Created by admin on Fri Dec 15 17:34:28 UTC 2023 , Edited by admin on Fri Dec 15 17:34:28 UTC 2023
PRIMARY
ChEMBL
CHEMBL38594
Created by admin on Fri Dec 15 17:34:28 UTC 2023 , Edited by admin on Fri Dec 15 17:34:28 UTC 2023
PRIMARY
Related Record Type Details
ENANTIOMER -> RACEMATE
PARENT -> SALT/SOLVATE
ENANTIOMER -> RACEMATE
Related Record Type Details
ACTIVE MOIETY